Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Rev Sci Tech ; 36(1): 245-263, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-28926011

RESUMO

Peste des petits ruminants (PPR) is an economically important livestock disease which affects a vast section of the small ruminant population in India. However, data on the incidence of PPR are limited and scant literature is available on the economic losses caused by the disease. In the present study, a structured sampling design was adopted, which covered the major agro-climatic regions of the country, to ascertain the morbidity and mortality rates of PPR. Available estimates of the economic losses in India due to various livestock diseases are based on single values of various epidemiological and economic parameters. Stochastic modelling was used to estimate the economic impact of PPR. Overall annual morbidity and mortality rates of PPR for small ruminants in India have been estimated from the sample as being 8%and 3.45%, respectively. The authors have analysed variations in these rates across species, age group, sex, season and region. The expected annual economic loss due to PPR in India ranges from as little as US $2 million to $18 million and may go up to US $1.5 billion; the most likely range of expected economic losses is between US $653 million and $669 million. This study thus reveals significant losses due to the incidence of PPR in small ruminants in India.


La peste des petits ruminants (PPR) est une maladie du bétail à fort impact économique. En Inde, une grande partie de la population des petits ruminants est affectée. Cependant, les données disponibles sur l'incidence de la PPR sont rares et très peu d'articles ont été consacrés aux pertes économiques causées par la maladie. Les auteurs présentent une étude basée sur un échantillonnage structuré couvrant les principales régions agro-climatiques du pays, visant à déterminer avec certitude les taux de morbidité et de mortalité de la PPR. Les estimations disponibles des pertes économiques induites par diverses maladies des animaux d'élevage sont basées sur des valeurs uniques correspondant à divers paramètres épidémiologiques et économiques. Les auteurs ont évalué l'impact économique de la PPR en utilisant un modèle stochastique. En se basant sur l'échantillon, les taux annuels de morbidité et de mortalité de la PPR chez les petits ruminants en Inde ont été respectivement estimés à 8 % et à 3,45 %. Les auteurs ont également analysé les variations de ces taux en fonction de l'espèce, du groupe d'âge, du sexe, de la saison et de la région. Les pertes annuelles attendues imputables à la PPR en Inde fluctuent d'un minimum de 2 millions de dollars US (USD) à 18 millions d'USD, mais elles peuvent atteindre 1,5 milliard d'USD ; la fourchette la plus probable des pertes économiques attendues se situe entre 653 millions et 669 millions d'USD. Cette étude souligne l'importance des pertes économiques liées à la présence de la PPR en Inde.


La peste de pequeños rumiantes (PPR) es una enfermedad del ganado que reviste importancia económica y afecta a un vasto segmento de la población de pequeños rumiantes de la India. Sin embargo, existen pocos datos sobre su incidencia y muy escasas referencias bibliográficas sobre las pérdidas económicas que ocasiona. Los autores describen un estudio encaminado a determinar las tasas de morbilidad y mortalidad por PPR a partir de un muestreo estructurado que abarcaba las principales regiones agroclimáticas del país. Las estimaciones existentes de las pérdidas económicas causadas en la India por diversas enfermedades del ganado están basadas en valores únicos de diversos parámetros epidemiológicos y económicos. Para estimar el impacto económico de la PPR se utilizó una modelización estocástica. A partir de la muestra se calculó que, en los pequeños rumiantes del país, los índices anuales de morbilidad y mortalidad totales por PPR se cifran en un 8% y un 3,45%, respectivamente. Los autores analizaron después las variaciones que exhiben esos índices por especie, grupo de edad, sexo, estación y región. La cuantía prevista de las pérdidas económicas anuales causadas por la PPR en el país oscila: de apenas 2 a 18 millones de dólares estadounidenses puede llegar hasta los 1 500 millones. El intervalo más probable de pérdidas económicas se sitúa entre 653 y 669 millones. El estudio demuestra pues que la incidencia de la PPR entre los pequeños rumiantes de la India provoca pérdidas de importante magnitud.


Assuntos
Peste dos Pequenos Ruminantes/economia , Peste dos Pequenos Ruminantes/epidemiologia , Animais , Clima , Feminino , Cabras , Incidência , Índia/epidemiologia , Masculino , Morbidade , Peste dos Pequenos Ruminantes/mortalidade , Estações do Ano , Ovinos , Inquéritos e Questionários
2.
Injury ; 26(5): 291-7, 1995 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-7649642

RESUMO

We retrospectively reviewed 32 elderly patients (mean age 71.7 years, range 66-83 years) with displaced tibial plateau fractures after a mean of 3.7 years (range 1-7 years) after operative treatment. Schatzker type 2 fracture was the commonest pattern of fracture (60.3 per cent). According to the modified Rasmussen clinical and radiographic criteria, there were nine excellent, 14 good, five fair and four poor results clinically, and 11 excellent, 12 good, six fair and three poor results radiographically. There was no significant correlation between the final radiographic appearance and clinical outcome. Fourteen patients mobilized postoperatively on a continuous passive motion machine followed by a cast brace had a better result than those mobilized in a cast brace alone, but the difference was not statistically significant (P = 0.29). Postoperative complications included deep vein thrombosis in two patients.


Assuntos
Fixação Interna de Fraturas , Fraturas da Tíbia/cirurgia , Idoso , Idoso de 80 Anos ou mais , Braquetes , Epífises/lesões , Consolidação da Fratura , Humanos , Terapia Passiva Contínua de Movimento , Radiografia , Estudos Retrospectivos , Fraturas da Tíbia/diagnóstico por imagem , Fraturas da Tíbia/reabilitação , Resultado do Tratamento
3.
Indian J Exp Biol ; 30(7): 567-73, 1992 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-1459628

RESUMO

Adult rats treated with a GnRH antagonist (Ac D2Nal1, D4Cl Phe2, DTrp3, DArg6, DAla10 GnRH; code: 103-289-10, National Institutes of Health, USA) for 5 weeks (250 micrograms/kg b.w) showed multiple degrees of impairment and atrophy of the genital organs concomitant with decreased serum levels of testosterone, LH and FSH. Inhibition of spermatogenesis was characterized by germ cell degeneration and overall decline in different cell numbers and in particular, spermatids of any kind were completely absent. Testosterone supplementation (60 micrograms/rat/day, sc) to GnRH antagonist treated rats, for the same period, significantly elevated the weights of the sex organs, and the serum levels of hormones. Spermatogenesis was improved both qualitatively and quantitatively; albeit failed to be restored back to control levels. Treatment with estradiol 17 beta (1 microgram/rat/day) for 5 weeks had insignificant effect on spermatogenesis but the weights of the genital organs (seminal vesicles by 19% and ventral prostate by 40%) and the levels of serum hormones (LH by 24%, FSH 22% and testosterone by 25%) were otherwise reduced. Administration of testosterone either alone or in combination with estradiol 17 beta had only a marginal effect on spermatogenesis or on other reproductive parameters. The results indicate a positive shift in the response of the testis and serum levels of gonadotropins to testosterone supplementation in rats treated with either GnRH antagonist or estradiol 17 beta.


Assuntos
Estradiol/farmacologia , Hormônio Liberador de Gonadotropina/fisiologia , Gonadotropinas/sangue , Testículo/efeitos dos fármacos , Testosterona/farmacologia , Animais , Hormônio Liberador de Gonadotropina/antagonistas & inibidores , Masculino , Ratos , Espermatogênese/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA